L Helson
Overview
Explore the profile of L Helson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
1276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Helson L
Int J Oncol
. 2011 May;
2(2):297-9.
PMID: 21573554
The cytotoxic effects of taxol, 10-deacetyltaxol, and cephalomannine at concentrations of 0.1 mug/ml to 10.0 mug/ml for one and 24 hours exposure were determined in two human glioblastoma multiforme and...
3.
Braverman S, Helson C, Abraham N, Helson L
Int J Oncol
. 2011 May;
2(1):97-103.
PMID: 21573522
The toxicity of deferoxamine, a potent iron chelator may be antagonized by hemin a potential iron source. Using the MTT assay we explored the effects of different concentrations and schedules...
4.
Helson C, Zahn Z, Helson L
Int J Oncol
. 2011 May;
5(5):1037-42.
PMID: 21559677
We evaluated the effect of PSC-833 a cyclosporine derivative for its MDR1 reversing activity on vincristine and adriamycin resistance in human neuroblastoma cell lines. The cell lines have high, intermittent...
5.
Helson C, Melamed M, Braverman S, Traganos F, Preti R, Helson L
Int J Oncol
. 2011 May;
7(1):51-6.
PMID: 21552805
A tumor cell line was derived and established from a bone marrow aspirate of a 41-year-old male who presented with motor symptoms of cord compression and an epidural tumor with...
6.
Deb G, Donfrancesco A, Sio L, Cozza R, Castellano A, Paole F, et al.
Anticancer Res
. 1998 May;
18(1B):489-92.
PMID: 9568167
Granulocyte colony stimulating factor (G-CSF) and granulocyte macrophage colony stimulating factor (GM-CSF) are cytokines which have been extensively administered as monotherapy to patients with a variety of hematopoietic disorders at...
7.
Ahmed T, Lake D, Beer M, Feldman E, Preti R, Seiter K, et al.
Bone Marrow Transplant
. 1997 Mar;
19(5):449-54.
PMID: 9052910
To evaluate a strategy of one cycle of dose-intensive chemotherapy for patients with Hodgkin's disease in sensitive relapse and two cycles for those with refractory disease, 122 patients received dose-intensive...
8.
Deb G, Habetswallner D, Helson L, De Sio L, Caniglia M, Donfrancesco A
Cancer Invest
. 1996 Jan;
14(2):109-11.
PMID: 8597895
We present a case report of a child who developed acute lymphoblastic leukemia, neurofibromatosis, optic glioma, and xanthogranulomatosis. This complex is unusual, not previously described, and appears to be a...
9.
Ahmed T, Lake D, Feldman E, Seiter K, Helson L, Mittelman A, et al.
Ann N Y Acad Sci
. 1995 Dec;
770:305-14.
PMID: 8597368
No abstract available.
10.
D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age
Donfrancesco A, Deb G, Dominici C, De Sio L, Inserra A, Boglino C, et al.
Anticancer Res
. 1995 Sep;
15(5B):2347-50.
PMID: 8572650
The role of intensive pre- and postoperative chemotherapy in unresectable nonmetastatic neuroblastoma is still controversial. A preoperative regimen that included deferoxamine, cyclophosphamide, etoposide, carboplatin and thiotepa (D-CECaT) was evaluated in...